Yi‐Chiang Hsu

1.8k total citations
72 papers, 1.5k citations indexed

About

Yi‐Chiang Hsu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yi‐Chiang Hsu has authored 72 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Yi‐Chiang Hsu's work include Genomics, phytochemicals, and oxidative stress (17 papers), Natural product bioactivities and synthesis (9 papers) and Curcumin's Biomedical Applications (8 papers). Yi‐Chiang Hsu is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (17 papers), Natural product bioactivities and synthesis (9 papers) and Curcumin's Biomedical Applications (8 papers). Yi‐Chiang Hsu collaborates with scholars based in Taiwan, United States and Pakistan. Yi‐Chiang Hsu's co-authors include Chi‐Chang Chang, Mon‐Juan Lee, Yie W. Chien, Chao‐Ming Hung, Ya-Min Cheng, Tzuu‐Yuan Huang, Ming‐Jenn Chen, Mei‐Jou Chen, Yu‐Tsai Lin and Shun‐Yao Ko and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and FEBS Letters.

In The Last Decade

Yi‐Chiang Hsu

70 papers receiving 1.5k citations

Peers

Yi‐Chiang Hsu
Ju‐Suk Nam South Korea
Ran Lu China
Ling Wu China
Ting Zhao China
Evguenia Arguiri United States
Kyung‐Ran Park South Korea
Ju‐Suk Nam South Korea
Yi‐Chiang Hsu
Citations per year, relative to Yi‐Chiang Hsu Yi‐Chiang Hsu (= 1×) peers Ju‐Suk Nam

Countries citing papers authored by Yi‐Chiang Hsu

Since Specialization
Citations

This map shows the geographic impact of Yi‐Chiang Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Chiang Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Chiang Hsu more than expected).

Fields of papers citing papers by Yi‐Chiang Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Chiang Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Chiang Hsu. The network helps show where Yi‐Chiang Hsu may publish in the future.

Co-authorship network of co-authors of Yi‐Chiang Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Chiang Hsu. A scholar is included among the top collaborators of Yi‐Chiang Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Chiang Hsu. Yi‐Chiang Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soong, Tien‐Chou, et al.. (2025). Cucurbitacin E Suppresses Adipogenesis and Lipid Accumulation in 3T3-L1 Adipocytes Without Cytotoxicity. Biomedicines. 13(8). 1826–1826.
3.
Tsai, Tai‐Hsin, et al.. (2023). JSI-124 Induces Cell Cycle Arrest and Regulates the Apoptosis in Glioblastoma Cells. Biomedicines. 11(11). 2999–2999. 2 indexed citations
4.
Tsai, Tai‐Hsin, Cheng-Yu Tsai, Sin‐Hua Moi, et al.. (2023). A Novel Synthetic Oleanolic Acid Derivative Inhibits Glioma Cell Proliferation by Regulating Cell Cycle G2/M Arrest. Pharmaceuticals. 16(5). 642–642. 3 indexed citations
5.
Cheng, An‐Chin, Ching‐Ju Shen, Chao‐Ming Hung, & Yi‐Chiang Hsu. (2019). Sulforaphane Decrease of SERTAD1 Expression Triggers G1/S Arrest in Breast Cancer Cells. Journal of Medicinal Food. 22(5). 444–450. 24 indexed citations
6.
Chen, Ming‐Jenn, et al.. (2017). Simvastatin induces G 1 arrest by up‐regulating GSK3β and down‐regulating CDK4/cyclin D1 and CDK2/cyclin E1 in human primary colorectal cancer cells. Journal of Cellular Physiology. 233(6). 4618–4625. 33 indexed citations
7.
Hung, Chao‐Ming, Yi‐Chiang Hsu, Tzu‐Yu Chen, Chi‐Chang Chang, & Mon‐Juan Lee. (2016). Cyclophosphamide promotes breast cancer cell migration through CXCR4 and matrix metalloproteinases. Cell Biology International. 41(3). 345–352. 15 indexed citations
8.
Wu, Chin‐San, Yi‐Chiang Hsu, Hsin‐Tzu Liao, & Yuxuan Cai. (2015). Antibacterial activity and in vitro evaluation of the biocompatibility of chitosan-based polysaccharide/polyester membranes. Carbohydrate Polymers. 134. 438–447. 39 indexed citations
9.
Liao, Fang, Yi‐Chiang Hsu, Sung‐Hsin Kuo, et al.. (2014). Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma. Blood Cancer Journal. 4(10). XX–XX. 25 indexed citations
10.
Lee, Mon‐Juan, et al.. (2013). Exogenous polyamines promote osteogenic differentiation by reciprocally regulating osteogenic and adipogenic gene expression. Journal of Cellular Biochemistry. 114(12). 2718–2728. 29 indexed citations
11.
Ko, Shun‐Yao, I‐Hsuan Lin, Tzong‐Ming Shieh, et al.. (2013). Cell Hypertrophy and MEK/ERK Phosphorylation are Regulated by Glyceraldehyde-Derived AGEs in Cardiomyocyte H9c2 Cells. Cell Biochemistry and Biophysics. 66(3). 537–544. 22 indexed citations
12.
Chang, Chi‐Chang, Chao‐Ming Hung, Yunru Yang, Mon‐Juan Lee, & Yi‐Chiang Hsu. (2013). Sulforaphane induced cell cycle arrest in the G2/M phase via the blockade of cyclin B1/CDC2 in human ovarian cancer cells. Journal of Ovarian Research. 6(1). 41–41. 55 indexed citations
13.
Cheng, Ya-Min, et al.. (2012). Influence of HPV16 E6/7 on the Expression of FGF2 and FGFR Type B in Cervical Carcinogenesis. Reproductive Sciences. 19(6). 580–586. 14 indexed citations
14.
Chang, Chi‐Chang, et al.. (2012). The cellular uptake and cytotoxic effect of curcuminoids on breast cancer cells. Taiwanese Journal of Obstetrics and Gynecology. 51(3). 368–374. 15 indexed citations
15.
Hsu, Yi‐Chiang, et al.. (2011). EARLY EXPERIMENTAL RESULTS OF COLORECTAL CARCINOMA CHEMOTHERAPEUTICS BY LIPOSOMAL CURCUMINOIDS. Digest Journal of Nanomaterials and Biostructures. 6(3). 1445–1456. 3 indexed citations
16.
Hsu, Yi‐Chiang, et al.. (2011). EXPERIMENTAL RESULTS OF COLORECTAL CANCER CHEMOPREVENTION BY CURCUMINOIDS LOADED NANO-CARRIER DRUG DELIVERY SYSTEM INCREASED IN VITRO BIOCOMPATIBILITY. Digest Journal of Nanomaterials and Biostructures. 6(3). 1187–1197. 5 indexed citations
17.
Hsu, Yi‐Chiang, Ming‐Jenn Chen, Yamei Yu, Shun‐Yao Ko, & Chi‐Chang Chang. (2010). Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid. Archives of Dermatological Research. 302(10). 717–724. 61 indexed citations
18.
Hsu, Yi‐Chiang, et al.. (2006). Nitric oxide in the pathogenesis of diffuse pulmonary fibrosis. Free Radical Biology and Medicine. 42(5). 599–607. 42 indexed citations
19.
Hsu, Yi‐Chiang, Michael Hsiao, Leng-Fang Wang, Yie W. Chien, & W. Robert Lee. (2006). Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation. Nitric Oxide. 14(4). 327–334. 44 indexed citations
20.
Hsu, Yi‐Chiang, Leng-Fang Wang, Yie W. Chien, & W. Robert Lee. (2006). Induction of TIMP-1 and HSP47 synthesis in primary keloid fibroblasts by exogenous nitric oxide. Journal of Dermatological Science. 45(1). 37–44. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026